PONTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.581
EU - Europa 9.447
AS - Asia 8.874
SA - Sud America 1.364
AF - Africa 191
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 17
Totale 43.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.053
GB - Regno Unito 3.257
SG - Singapore 2.857
IT - Italia 2.185
CN - Cina 2.121
HK - Hong Kong 1.098
BR - Brasile 1.046
VN - Vietnam 948
SE - Svezia 907
DE - Germania 767
FI - Finlandia 510
UA - Ucraina 481
BD - Bangladesh 454
RU - Federazione Russa 368
TR - Turchia 347
FR - Francia 345
CA - Canada 322
IN - India 214
KR - Corea 192
BG - Bulgaria 169
MX - Messico 141
ID - Indonesia 128
AR - Argentina 103
IQ - Iraq 90
NL - Olanda 83
JP - Giappone 70
IE - Irlanda 58
ZA - Sudafrica 57
EC - Ecuador 53
PL - Polonia 51
ES - Italia 47
AE - Emirati Arabi Uniti 41
PK - Pakistan 39
CO - Colombia 38
MY - Malesia 37
VE - Venezuela 33
CL - Cile 30
MA - Marocco 29
BE - Belgio 28
LT - Lituania 25
SA - Arabia Saudita 25
JO - Giordania 24
EG - Egitto 23
KE - Kenya 23
PH - Filippine 23
UZ - Uzbekistan 23
AT - Austria 22
PY - Paraguay 21
TH - Thailandia 21
CH - Svizzera 20
AU - Australia 19
PE - Perù 19
RO - Romania 19
NP - Nepal 17
CZ - Repubblica Ceca 15
AZ - Azerbaigian 13
TN - Tunisia 13
CR - Costa Rica 12
DZ - Algeria 12
PT - Portogallo 12
DO - Repubblica Dominicana 11
HU - Ungheria 11
IR - Iran 11
KZ - Kazakistan 11
BO - Bolivia 10
EU - Europa 10
IL - Israele 10
LU - Lussemburgo 10
PA - Panama 10
NO - Norvegia 9
PS - Palestinian Territory 9
NG - Nigeria 8
UY - Uruguay 8
DK - Danimarca 7
JM - Giamaica 7
LB - Libano 7
RS - Serbia 7
BH - Bahrain 6
AL - Albania 5
ET - Etiopia 5
GT - Guatemala 5
KG - Kirghizistan 5
MD - Moldavia 5
OM - Oman 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
GE - Georgia 4
HN - Honduras 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
HR - Croazia 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
Totale 43.446
Salva come PNG Salva come JPEG
Città #
Fairfield 2.538
Southend 2.473
Ashburn 2.064
Santa Clara 1.902
Singapore 1.673
Woodbridge 1.579
Houston 1.175
Hong Kong 1.085
Seattle 981
Chandler 923
Wilmington 851
Jacksonville 832
Cambridge 814
Dearborn 786
Ann Arbor 661
San Jose 609
Chicago 607
Nyköping 543
Beijing 494
Los Angeles 476
Hefei 472
London 422
Helsinki 353
Council Bluffs 340
Modena 284
Ho Chi Minh City 283
Salt Lake City 247
The Dalles 229
Hanoi 228
New York 218
San Diego 209
Princeton 203
Ottawa 193
Izmir 188
Milan 188
Seoul 180
Sofia 167
Eugene 155
Rome 145
Shanghai 137
Buffalo 131
Lauterbourg 127
Tampa 123
Elk Grove Village 115
Dallas 109
Moscow 97
Orem 91
São Paulo 89
Jakarta 88
Bremen 81
Frankfurt am Main 75
Munich 74
Sterling 72
Lancaster 61
Phoenix 56
Dublin 55
Redwood City 54
Grafing 51
Columbus 50
Da Nang 47
Tokyo 47
Dong Ket 44
Bologna 43
Haiphong 43
Des Moines 40
Warsaw 39
Guangzhou 38
Miami 38
Denver 37
Atlanta 36
Rio de Janeiro 36
Toronto 36
Boardman 35
Norwalk 35
Brooklyn 34
Turin 34
Fremont 33
Chennai 32
Detroit 31
Montreal 31
Belo Horizonte 30
Mexico City 30
Baghdad 27
Dulles 27
Naples 27
Palermo 27
New Delhi 25
Miano 24
Redondo Beach 24
Dongguan 23
Nanjing 23
Curitiba 22
Pittsburgh 22
Quito 22
San Mateo 22
Stockholm 22
Kunming 21
Mumbai 21
Turku 21
Amman 20
Totale 30.775
Salva come PNG Salva come JPEG
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 610
Neoplasie maligne e benigne associate al melanoma multiplo: coinvolgimento di MITF, PTEN and CDKN2A nella cancerogenesi melanocitaria multipla. 581
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 458
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 452
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 451
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients 448
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 442
Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ. 441
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 438
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 426
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 414
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor 413
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 407
"Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass 404
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 402
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients 398
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 393
Caso di Neurofibromatosi diagnosticata a 71 anni 389
Aetiology of colorectal cancer and relevance of monogenic inheritance. 380
Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics. 376
Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi 374
A novel CYLD germline mutation in Brooke-Spiegler syndrome. 372
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 369
Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome 369
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 368
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker 363
Variegated Dermoscopy of in situ Melanoma. 362
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 361
Ameloblastoma: A neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome 360
Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria 358
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. 358
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 355
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 354
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival 347
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 346
Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report 345
Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report 344
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 344
High Magnification Digital Dermoscopy of Basal Cell Carcinoma: A Single-centre Study on 400 cases. 340
The impact of histopathologic diagnosis on the proper management of testis neoplasms. 335
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 335
Grey-blue regression in melanoma in situ-evaluation on 111 cases. 334
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 333
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 333
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 332
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology 331
Biomarkers associated with COVID-19 disease progression 328
Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy 327
Dermoscopy of small melanomas: just a miniaturized dermoscopy? 325
Confocal microscopy characterization of BRAFV600E mutated melanomas 324
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 323
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 322
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors. 321
Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients 320
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome 320
Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons 320
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 319
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 317
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas 313
Microsatellite instability and colorectal cancer prognosis. 303
Mismatch Repair Gene Deficiency and Genetic Anticipation in Lynch Syndrome 302
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. 296
Desmoplastic melanoma: a challenge for the oncologist 295
Seminal cell free DNA concentration levels discriminate between prostate cancer and benign prostatic hyperplasia 293
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 292
Seminal cell-free DNA assessment as a novel prostate cancer biomarker 289
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 287
Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome 286
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma 283
Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies 280
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 278
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 277
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors? 275
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 274
Diagnosis of BCC by multiphoton laser tomography. 272
Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study on 140 cases. 272
Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past? 272
Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. 272
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 270
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 269
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 264
The dermoscopic variability of pigment network in melanoma in situ. 263
Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers 262
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 261
High-resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. 260
Are the neck malignant melanomas different from the ones affecting the head? Clinicopathologic, dermoscopic and prognostic findings 260
Biological characterization of mucinous carcinoma of the colon and rectum 259
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 258
Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics 257
Microsatellite instability, immunohistochemistry and germline mismatch repair gene mutations for the diagnosis of Muir-Torre syndrome in immunosuppressed patients 256
Relationship between histological and computer based assessment of melanoma diameter and thickness in head & neck vs. trunk melanoma. 254
Stem cell properties in cell cultures from different stage of melanoma progression. 247
High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence lifetime imaging. 245
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. 245
Erratum: Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanoma (Disease Markers) 245
Distinctive clinical and dermoscopic features of BRAFp.V600K mutated melanomas. 243
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 243
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 241
Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge 240
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report 236
Totale 33.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.822
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021339 0 0 0 0 0 0 0 0 0 0 0 339
2021/20223.306 260 412 347 182 73 176 175 184 360 238 553 346
2022/20232.776 357 345 210 236 329 383 59 255 316 51 133 102
2023/20241.862 86 90 129 174 383 193 193 216 53 48 100 197
2024/20256.728 193 63 92 405 1.297 1.049 455 429 707 365 677 996
2025/202613.122 637 376 887 1.800 2.756 810 1.377 615 1.183 1.035 1.017 629
Totale 43.903